We conclude by mentioning that since high levels of CA-125 are not exclusive to ovarian cancers (being found also in patients with breast, lung or gastrointestinal cancers [2]), and since IL-7 is a cytokine that characterises an active immune response, we hypothesise that a combined use of CA-125 and IL-7 could be employed to detect possible early signs of other types of cancers. The gene discussed is IL7; the disease is ovarian carcinoma.